[ { "id": 403, "name": "Human Dx", "slug": "human-dx", "former_names": [ "Step 4" ], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "http://humandx.org", "all_locations": "San Francisco, CA, USA", "long_description": "The Human Diagnosis Project (also referred to as “Human Dx” or “the Project”) is a worldwide effort to build an open medical intelligence system that maps the steps to help any patient. By combining collective intelligence with machine learning, Human Dx intends to enable more accurate, affordable, and accessible care for all", "one_liner": "The Human Diagnosis Project.", "team_size": 11, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare IT", "launched_at": 1336096619, "tags": [ "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2012", "status": "Active", "industries": [ "Healthcare", "Healthcare IT" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/human-dx", "api": "https://yc-oss.github.io/api/batches/summer-2012/human-dx.json" }, { "id": 729, "name": "Ginkgo Bioworks", "slug": "ginkgo-bioworks", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/d8427e9e647b115fc9f1f760c7a1324f1d2c02ef.png", "website": "http://ginkgobioworks.com", "all_locations": "Boston, MA, USA", "long_description": "Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.", "one_liner": "Our mission is to make biology easier to engineer.", "team_size": 641, "industry": "Healthcare", "subindustry": "Healthcare -> Industrial Bio", "launched_at": 1400927505, "tags": [ "Synthetic Biology", "Diagnostics", "Automation" ], "tags_highlighted": [], "top_company": true, "isHiring": true, "nonprofit": false, "batch": "Summer 2014", "status": "Public", "industries": [ "Healthcare", "Industrial Bio" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/ginkgo-bioworks", "api": "https://yc-oss.github.io/api/batches/summer-2014/ginkgo-bioworks.json" }, { "id": 734, "name": "One Codex", "slug": "one-codex", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/5eedcdf8d152fac7180dc5402647f58cd164448a.png", "website": "https://www.onecodex.com", "all_locations": "Boston, MA, USA; San Francisco, CA, USA", "long_description": "One Codex is a data platform for applied microbial genomics, enabling new and valuable applications in clinical diagnostics, food safety, and biosecurity. Acquired by Invitae (NVTA) in February 2021. Spun out as an independent company in September 2022.", "one_liner": "Data platform for metagenomics and the microbiome.", "team_size": 16, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare IT", "launched_at": 1401532729, "tags": [ "Biotech", "Diagnostics", "Genomics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2014", "status": "Acquired", "industries": [ "Healthcare", "Healthcare IT" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/one-codex", "api": "https://yc-oss.github.io/api/batches/summer-2014/one-codex.json" }, { "id": 805, "name": "Lucira Health", "slug": "lucira-health", "former_names": [ "Diassess" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/c16f624e7c7aac96877a792583de496fc66b4a02.png", "website": "https://www.lucirahealth.com/", "all_locations": "Emeryville, CA, USA", "long_description": "Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.", "one_liner": "Next generation infectious disease test kits", "team_size": 43, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1416306600, "tags": [ "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2015", "status": "Public", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/lucira-health", "api": "https://yc-oss.github.io/api/batches/winter-2015/lucira-health.json" }, { "id": 962, "name": "Cofactor Genomics", "slug": "cofactor-genomics", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0138772cf18d9846bdac1578f7edd2288e7e4142.png", "website": "http://cofactorgenomics.com", "all_locations": "St. Louis, MO, USA", "long_description": "Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes.\r\n\r\nLed by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. \r\n\r\nThe team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. \r\n\r\nAfter a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. \r\n\r\nCurrent investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).", "one_liner": "Cofactor closes the precision medicine gap with predictive diagnostics", "team_size": 13, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1433394319, "tags": [ "Medical Devices", "Biotech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2015", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/cofactor-genomics", "api": "https://yc-oss.github.io/api/batches/summer-2015/cofactor-genomics.json" }, { "id": 1014, "name": "Luminist Labs", "slug": "luminist-labs", "former_names": [ "Luminist" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/b2a824d7b13f5cb87d6f2567fb9307570a0c1d46.png", "website": "http://luministlabs.com", "all_locations": "Newark, CA, USA", "long_description": "Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.", "one_liner": "Diagnostic platform for early detection of liver disease", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1447311916, "tags": [ "Medical Devices", "Diagnostics", "Genomics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2016", "status": "Acquired", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/luminist-labs", "api": "https://yc-oss.github.io/api/batches/winter-2016/luminist-labs.json" }, { "id": 1023, "name": "Unima", "slug": "unima", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/6c2c011e4d98e07f268e9d5fe993f2508a4a51e7.png", "website": "http://www.unimadx.com", "all_locations": "Zapopan, Jal., Mexico", "long_description": "Unima developed a fast and low-cost diagnostic and real-time disease surveillance that allows anyone to diagnose a disease directly where the patient is, without using lab equipment, with results in 15 minutes and at a very low cost.", "one_liner": "Fast and low-cost diagnostics for real time disease surveillance", "team_size": 26, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1447312816, "tags": [ "Health Tech", "Biotech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2016", "status": "Inactive", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Mexico", "Latin America" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/unima", "api": "https://yc-oss.github.io/api/batches/winter-2016/unima.json" }, { "id": 1072, "name": "Silver", "slug": "silver", "former_names": [], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "http://www.scansilver.com/", "all_locations": "Cupertino, CA, USA", "long_description": "At Silver, they are building the world's first miniaturized Raman spectroscope for consumers. Our spectroscope, combined with our proprietary nanoparticle substrates, enables our users to detect many contaminants instantaneously.", "one_liner": "Low cost consumer device for toxin detection. ", "team_size": 0, "industry": "Consumer", "subindustry": "Consumer -> Consumer Electronics", "launched_at": 1447748416, "tags": [ "Hard Tech", "Diagnostics", "Nanotechnology" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2016", "status": "Inactive", "industries": [ "Consumer", "Consumer Electronics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/silver", "api": "https://yc-oss.github.io/api/batches/winter-2016/silver.json" }, { "id": 1109, "name": "BillionToOne", "slug": "billiontoone", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/7374f48e30f2dabadb3413903af69fcda589d67f.png", "website": "https://www.billiontoone.com", "all_locations": "Menlo Park, CA, USA", "long_description": "BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.", "one_liner": "The genetic testing platform detecting and measuring disease.", "team_size": 300, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1453416611, "tags": [ "Diagnostics", "Genomics" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2017", "status": "Public", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/billiontoone", "api": "https://yc-oss.github.io/api/batches/summer-2017/billiontoone.json" }, { "id": 1243, "name": "Kenota (formerly ExVivo Labs)", "slug": "kenota", "former_names": [ "ExVivo Labs" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/7e389cbf09ff94eb9242f60bd9522b162a2464ff.png", "website": "https://kenota.com/", "all_locations": "Kitchener, ON, Canada", "long_description": "", "one_liner": "Kenota is revolutionizing the way we test for disease ", "team_size": 35, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1461643818, "tags": [ "Healthcare", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2016", "status": "Inactive", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Canada", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/kenota", "api": "https://yc-oss.github.io/api/batches/summer-2016/kenota.json" }, { "id": 1532, "name": "Delee", "slug": "delee", "former_names": [ "Semka Technologies" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/badd1b077ec76be8053aae9a5daf9d6f1afd8d56.png", "website": "http://www.delee.co ", "all_locations": "Monterrey, N.L., Mexico", "long_description": "Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells. ", "one_liner": "Blood testing device for early diagnosis of cancer and treatment…", "team_size": 18, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1478742617, "tags": [ "Medical Devices", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2017", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Mexico", "Latin America" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/delee", "api": "https://yc-oss.github.io/api/batches/winter-2017/delee.json" }, { "id": 1610, "name": "Darmiyan", "slug": "darmiyan", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3be6f1febb81bc5a98e11a2a64bc294e0cee4eff.png", "website": "https://www.darmiyan.com/", "all_locations": "San Francisco, CA, USA", "long_description": "Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.", "one_liner": "Early detection of Alzheimer's disease", "team_size": 8, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1493265720, "tags": [ "Artificial Intelligence", "Machine Learning", "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2017", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/darmiyan", "api": "https://yc-oss.github.io/api/batches/summer-2017/darmiyan.json" }, { "id": 1933, "name": "Clear Gene", "slug": "clear-gene", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/4c3988b74387b722e9f7364d78e224dbb7a5e2f7.png", "website": "https://cleargene.com", "all_locations": "San Carlos, CA, USA", "long_description": "", "one_liner": "Our tests help eradicate cancer by telling doctors whether they got…", "team_size": 4, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1616188654, "tags": [ "Healthcare", "Diagnostics", "Women's Health", "Oncology" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2018", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/clear-gene", "api": "https://yc-oss.github.io/api/batches/summer-2018/clear-gene.json" }, { "id": 1949, "name": "Scanwell Health", "slug": "scanwell-health", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/c239150be35c09cf1a917f12c84d7db6f28a85a6.png", "website": "https://www.scanwellhealth.com", "all_locations": "Los Angeles, CA, USA; Remote", "long_description": "Scanwell Health makes healthcare more accessible through smartphone-enabled, at-home diagnostics. Scanwell's innovative approach lets people test from anywhere, skip the waiting room and get same-day results. By quickly diagnosing acute illnesses, chronic diseases and rare conditions, Scanwell accelerates the path to treatment. Our first product is the only FDA-cleared over-the-counter app that provides testing and treatment for urinary tract infections (UTIs).", "one_liner": "Smartphone-enabled, at-home diagnostics", "team_size": 13, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1525226775, "tags": [ "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2018", "status": "Acquired", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Fully Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/scanwell-health", "api": "https://yc-oss.github.io/api/batches/summer-2018/scanwell-health.json" }, { "id": 12067, "name": "PNOĒ", "slug": "pnoe", "former_names": [], "small_logo_thumb_url": "/company/thumb/missing.png", "website": "", "all_locations": "Athens, Greece; Miami, FL, USA", "long_description": "PNOĒ enables health professionals to provide science-backed bio-optimization through breath analysis. For 100+ years, breath analysis (AKA metabolic testing, VO2max) has been the gold standard in anti-aging quantification, nutrition prescription, and evaluation of most critical systems, including the heart, lungs, cells, and nervous system. Until recently, it was only available in sophisticated clinics and regarded as the most valuable but underutilized assessment in medicine. PNOĒ changed that through the first easy-to-use clinical-grade breath analysis device, proprietary software package, and dedicated metabolic expert support. Through a non-invasive 10 min breath test, PNOĒ analyzes the human breath and prescribes a personalized nutrition, exercise, breathwork, and bio-optimization (i.e., red light therapy, hyperbaric chamber, IV therapy, etc.) program based on one’s biological limitations. 3,000+ health professionals trust PNOĒ because it personalizes the clients’ journey through their clinics, builds retention by quantifying progress, and enables the upsell of personalized nutrition and breathwork. All this without any effort, time commitment, or upfront cost. PNOĒ has been independently validated by Georgetown University, VA in Maryland, and Rutgers University and is trusted by leading institutions including Cenegenics, Dais Cove, MIT, UCLA, Pan Pacific, CLMBR, UCS, OURA, TONAL, Spartan Racing, and Paris Saint Germain. ", "one_liner": "Enabling health professionals to prescribe clinical-grade wellness…", "team_size": 70, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare Services", "launched_at": 1601260702, "tags": [ "Medical Devices", "Digital Health", "Telemedicine", "Diagnostics", "Primary Care" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Winter 2019", "status": "Active", "industries": [ "Healthcare", "Healthcare Services" ], "regions": [ "Greece", "United States of America", "Europe", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/pnoe", "api": "https://yc-oss.github.io/api/batches/winter-2019/pnoe.json" }, { "id": 13220, "name": "Simple Strips", "slug": "simple-strips", "former_names": [ "Simple Strips (Lambert Labs Inc.)" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/7b48d64634d795b4a612106fa51ef61ddc04d681.png", "website": "https://simplestrips.com", "all_locations": "San Francisco, CA, USA", "long_description": "", "one_liner": "Low-cost blood glucose test strips scanned with a smartphone camera…", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1583979245, "tags": [ "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2020", "status": "Inactive", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/simple-strips", "api": "https://yc-oss.github.io/api/batches/winter-2020/simple-strips.json" }, { "id": 13442, "name": "Isabl", "slug": "isabl", "former_names": [ "Isabl Technologies" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/2ee5c89ed172cfb330b2cb9f0f5e0f1a93886387.png", "website": "http://isabl.io", "all_locations": "New York, NY, USA; Remote", "long_description": "Isabl has developed software that can analyze the entire genome of cancer patients.\r\n\r\nToday, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations.\r\n\r\nOur breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.", "one_liner": "Cancer tests based on whole genome and transcriptome data.", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1652922754, "tags": [ "Biotech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2020", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Fully Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/isabl", "api": "https://yc-oss.github.io/api/batches/winter-2020/isabl.json" }, { "id": 21737, "name": "LSK Technologies", "slug": "lsk-technologies", "former_names": [ "LSK Technologies Inc." ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/ca1d558dc356d3f2e123fbc02692cf8bafa1a131.png", "website": "https://www.lifesci-key.com/", "all_locations": "Toronto, ON, Canada", "long_description": "", "one_liner": "A diagnostic lab in a box", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1599762607, "tags": [ "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2020", "status": "Acquired", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Canada", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/lsk-technologies", "api": "https://yc-oss.github.io/api/batches/summer-2020/lsk-technologies.json" }, { "id": 22080, "name": "Orange Health Labs", "slug": "orange-health-labs", "former_names": [ "Orange Health" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3e07e4f8af878b1c646ca1ca04c557bb4e10c4a8.png", "website": "http://www.orangehealth.in", "all_locations": "Bengaluru, KA, India", "long_description": "Orange Health Labs is India’s leading on-demand diagnostics lab for urban consumers, offering 30-minute at-home sample collection and 6 hour reports across the top cities of India \r\n\r\nLaunched in January 2021, Orange Health Labs is amongst the most loved healthcare brands in India and is backed by some of the world’s leading investors like Accel, General Catalyst, Y Combinator, Bertelsmann India, Amazon, and others. ", "one_liner": "India's Fastest Diagnostics Service", "team_size": 1100, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1599762607, "tags": [ "Consumer Health Services", "Health Tech", "Healthcare", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2020", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "India", "South Asia" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/orange-health-labs", "api": "https://yc-oss.github.io/api/batches/summer-2020/orange-health-labs.json" }, { "id": 22700, "name": "Moichor", "slug": "moichor", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/d684e5402c05c9cc17faca949952294cf3f7e3e0.png", "website": "https://moichor.com/", "all_locations": "San Francisco, CA, USA", "long_description": "Leveraging AI to provide veterinarians with more accurate and affordable diagnostics. \r\n\r\n\r\n", "one_liner": "AI Powered Animal Diagnostics", "team_size": 29, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1610738476, "tags": [ "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/moichor", "api": "https://yc-oss.github.io/api/batches/winter-2021/moichor.json" }, { "id": 23146, "name": "Redcliffe Lifetech", "slug": "redcliffe-lifetech", "former_names": [ "Redcliffe Lifesciences" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/b9e3c4bc934297fbdde47eea1cf4c9de32e1a325.png", "website": "http://redcliffelabs.com", "all_locations": "Delhi, DL, India; Gurugram, HR, India; Noida, UP, India", "long_description": "Redcliffe Labs (a unit of Redcliffe Lifetech Inc) provides diagnostics with a comprehensive portfolio approach both with routine and specialised test menus with advanced testing labs all over India. Its digital first approach with on-demand 1-hour home collection and same day report is disrupting the way diagnostics is delivered today and thus is the fastest growing in India. \r\n\r\nRedcliffe Labs is providing 3500+ tests across its wide network of labs and collection centres. The company has served about millions of Indians and is processing more than 250K+ test parameters daily. The test portfolio is very wide including routine pathology tests, advanced genetic screening, research-based DNA tests in reproductive health, cancer and wellness/fitness. The easy to interpret smart reports provide key health check-points, which can help in diagnosing and treating both chronic and acute diseases on time. Redcliffe Labs has pioneered Drone technology adoption in the diagnostic sector by opening up the first commercial corridor from Uttarkashi to Dehradun. The company currently has 30+ labs and 700+ authorised collection centres in more than 120 cities across India. \r\n\r\nRedcliffe's vision is to provide world-class diagnostic services to people across the Indian sub-continent in an affordable manner.", "one_liner": "Redcliffe Labs is India's Largest Omni-channel Diagnostics platform ", "team_size": 3500, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1614617903, "tags": [ "Consumer Health Services", "Health Tech", "Digital Health", "Healthcare", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "India", "South Asia" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/redcliffe-lifetech", "api": "https://yc-oss.github.io/api/batches/winter-2021/redcliffe-lifetech.json" }, { "id": 23884, "name": "AOA Dx", "slug": "aoa-dx-inc", "former_names": [ "AOA Dx Inc." ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/664577ac1be84d91114d755fa8d02fcd2a69deb8.png", "website": "https://www.aoadx.com/", "all_locations": "Denver, CO, USA; Cambridge, MA, USA", "long_description": "AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology. ", "one_liner": "Blood Test for Early Detection of Ovarian Cancer ", "team_size": 25, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1624286416, "tags": [ "Healthcare", "Diagnostics", "Women's Health" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": true, "app_answers": true, "question_answers": false, "url": "https://www.ycombinator.com/companies/aoa-dx-inc", "api": "https://yc-oss.github.io/api/batches/summer-2021/aoa-dx-inc.json" }, { "id": 24368, "name": "Yemaachi Biotechnology", "slug": "yemaachi-biotechnology", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0f20c99ceb3dc4f5663a9b43329248c249511272.png", "website": "https://yemaachi.com/", "all_locations": "Accra, Greater Accra Region, Ghana", "long_description": "Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones.\r\nWith our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.", "one_liner": "Diversifying precision cancer diagnostics and treatments", "team_size": 16, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1627837386, "tags": [ "Biotech", "Diagnostics", "Therapeutics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "Ghana", "Africa" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/yemaachi-biotechnology", "api": "https://yc-oss.github.io/api/batches/summer-2021/yemaachi-biotechnology.json" }, { "id": 24819, "name": "Adravision", "slug": "adravision", "former_names": [ "Adra" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0af36732c31f9de500d8cee39a790da8b6870407.png", "website": "https://www.adra.ai", "all_locations": "Singapore, Singapore; Remote", "long_description": "We build automation solutions powered by AI to improve the efficiency of diagnostics, documentation, and patient education for dental clinics. Our technology is also used by dental insurance companies to process large volumes of claims by analyzing unstructured data like X-rays, narratives, and documents.\r\n\r\nWe're a dentist and clinic owner, a computer vision expert, and a bioscientist.\r\n\r\nhttps://www.adra.ai/\r\n", "one_liner": "Automation for dental clinics and insurance companies.", "team_size": 8, "industry": "Healthcare", "subindustry": "Healthcare -> Healthcare IT", "launched_at": 1625793079, "tags": [ "Artificial Intelligence", "Healthcare", "Health Insurance", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2021", "status": "Active", "industries": [ "Healthcare", "Healthcare IT" ], "regions": [ "Singapore", "Southeast Asia", "Remote", "Fully Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/adravision", "api": "https://yc-oss.github.io/api/batches/summer-2021/adravision.json" }, { "id": 25110, "name": "Spot Health", "slug": "spot-health", "former_names": [ "Spot" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/0ffec8c45537c093646d5b42339f3c6147d96cd7.png", "website": "https://spotdx.com", "all_locations": "Cincinnati, OH, USA", "long_description": "Spot is building the infrastructure to support the future of at-home diagnostics. Our fully white-labeled platform helps brands offer lab-analyzed diagnostic tests using at-home collection kits. Companies simply order tests via our API, and we handle the rest—the collection kits, the logistics, physician authorization, and the lab integrations.", "one_liner": "At-home diagnostics as a service", "team_size": 9, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1647881296, "tags": [ "Telehealth", "Healthcare", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/spot-health", "api": "https://yc-oss.github.io/api/batches/winter-2022/spot-health.json" }, { "id": 25285, "name": "Scout", "slug": "scout-2", "former_names": [ "Uh-Oh Labs", "Scout (formerly Uh-Oh Labs)" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/aef2a50967bbb0e1e0f4bc9ebba4727befed3822.png", "website": "http://scouthealth.com", "all_locations": "Santa Clara, CA, USA", "long_description": "Digital health holds a lot of potential but is ignoring a growing problem: diagnostic testing. Without this data, providers and organizations will be limited in the services they can provide patients at home.\r\n\r\nScout has developed a platform - Hub, test kits, and app - that delivers health testing at home with 10x lower development cost and 3x lower per-test price. Our patented tech also meets performance requirements for medical diagnoses and integrates with the current healthcare tech stack. Scout’s technology is poised to disrupt the outdated $33Bn diagnostic market by democratizing testing while dramatically improving the patient experience.\r\n\r\nScout has received $16M in non-dilutive funding from the NIH and other organizations to fully de-risk our platform, and our pipeline includes a diverse test menu for primary care (e.g. respiratory and sexual health), wellness (e.g. gut health), and chronic conditions (e.g. certain cancers). We have already received FDA authorization for our platform in clinical settings and are planning to launch our flagship Scout Hub in 2024.", "one_liner": "The smart testing platform that unlocks digital health at home.", "team_size": 12, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1645122247, "tags": [ "Consumer Health Services", "COVID-19", "Health Tech", "Diagnostics", "Consumer Products" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2022", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/scout-2", "api": "https://yc-oss.github.io/api/batches/winter-2022/scout-2.json" }, { "id": 26751, "name": "Signatur Biosciences", "slug": "signatur-biosciences", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/3bad55d9462a3252670af9b86ed4d9abc2a388f4.png", "website": "https://www.signatur.bio/", "all_locations": "London, England, United Kingdom", "long_description": "We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.", "one_liner": "Simple tests for complex diseases.", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1657207796, "tags": [ "Biotech", "Healthcare", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2022", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United Kingdom", "Europe", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/signatur-biosciences", "api": "https://yc-oss.github.io/api/batches/summer-2022/signatur-biosciences.json" }, { "id": 27224, "name": "InVision Medical Technology", "slug": "invision-medical-technology", "former_names": [ "EchoNet", "InVision" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/7c4e725df0c7bd2ece41618fab3a7e4124841d58.png", "website": "http://invisionmedtech.com/", "all_locations": "San Francisco, CA, USA", "long_description": "At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.", "one_liner": "AI Diagnosis of Heart Disease", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare", "launched_at": 1661551534, "tags": [ "Artificial Intelligence", "Health Tech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2022", "status": "Active", "industries": [ "Healthcare" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/invision-medical-technology", "api": "https://yc-oss.github.io/api/batches/summer-2022/invision-medical-technology.json" }, { "id": 28425, "name": "Pando Bioscience", "slug": "pando-bioscience", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/fcb2bf6569db61c3592824679114d563e4d1438c.png", "website": "https://pando.bio/", "all_locations": "Boston, MA, USA", "long_description": "Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.", "one_liner": "Gen-AI Designed Enzymes for Pharmaceutical Innovation", "team_size": 5, "industry": "Healthcare", "subindustry": "Healthcare -> Industrial Bio", "launched_at": 1675971158, "tags": [ "Generative AI", "Synthetic Biology", "Biotech", "Diagnostics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Winter 2023", "status": "Active", "industries": [ "Healthcare", "Industrial Bio" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/pando-bioscience", "api": "https://yc-oss.github.io/api/batches/winter-2023/pando-bioscience.json" }, { "id": 28891, "name": "Numen", "slug": "numen", "former_names": [ "Cleancard" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/801ff758c035f5849acfdcd35329ec161bd30cef.png", "website": "https://www.numen.com", "all_locations": "San Francisco, CA, USA", "long_description": "", "one_liner": "Engineering a future without cancer deaths.", "team_size": 18, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1691571179, "tags": [ "Machine Learning", "Biotech", "Healthcare", "Diagnostics", "AI" ], "tags_highlighted": [], "top_company": false, "isHiring": true, "nonprofit": false, "batch": "Summer 2023", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United States of America", "America / Canada", "Remote", "Partly Remote" ], "stage": "Growth", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/numen", "api": "https://yc-oss.github.io/api/batches/summer-2023/numen.json" }, { "id": 29694, "name": "AminoAnalytica", "slug": "aminoanalytica", "former_names": [], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/f7d5463656052d09bd1bc697531992af867d844c.png", "website": "https://www.aminoanalytica.com", "all_locations": "London, United Kingdom", "long_description": "We design point-of-care molecular diagnostics for emerging biological threats - in weeks, not 12+ months.", "one_liner": "The AI scientist for always-on biodefense", "team_size": 3, "industry": "Healthcare", "subindustry": "Healthcare -> Diagnostics", "launched_at": 1715962434, "tags": [ "Nanosensors", "Synthetic Biology", "Biotech", "Diagnostics", "Therapeutics" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2024", "status": "Active", "industries": [ "Healthcare", "Diagnostics" ], "regions": [ "United Kingdom", "Europe", "Remote", "Partly Remote" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/aminoanalytica", "api": "https://yc-oss.github.io/api/batches/summer-2024/aminoanalytica.json" }, { "id": 29749, "name": "Biocartesian", "slug": "biocartesian", "former_names": [ "coordna bio" ], "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/829faf276e5fc759cb0c8e72860cd6cdab552050.png", "website": "https://www.biocartesian.com", "all_locations": "San Francisco, CA, USA", "long_description": "Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.", "one_liner": "Converting biology into digital molecular maps", "team_size": 2, "industry": "Healthcare", "subindustry": "Healthcare -> Drug Discovery and Delivery", "launched_at": 1724915415, "tags": [ "Hard Tech", "B2B", "Biotech", "Diagnostics", "Drug discovery" ], "tags_highlighted": [], "top_company": false, "isHiring": false, "nonprofit": false, "batch": "Summer 2024", "status": "Active", "industries": [ "Healthcare", "Drug Discovery and Delivery" ], "regions": [ "United States of America", "America / Canada" ], "stage": "Early", "app_video_public": false, "demo_day_video_public": false, "app_answers": null, "question_answers": false, "url": "https://www.ycombinator.com/companies/biocartesian", "api": "https://yc-oss.github.io/api/batches/summer-2024/biocartesian.json" } ]